Guillain-Barre Syndrome: An Unusual Presentation of West Nile Virus Infection
Neurol 55:144-146, Ahmed,S. et al, 2000
FLAIR MRI in sporadic Creutzfeldt-Jakob Disease
Neurol 55:147-148, Vrancken,A.F.J.E. et al, 2000
Psychological Stress and the Subsequent Appearance of New Brain MRI Lesions in MS
Neurol 55:55-61, Mohr,D.C. et al, 2000
Transplantation of Cultured Human Neuronal Cells for Patients With Stroke
Neurol 55:565-569, 467, Kondziolka,D. et al, 2000
Reversible Tacrolimus-Induced Neurotoxicity Isolated to the Brain Stem
AJNR 21:1251-1254, Oliverio,P.J. et al, 2000
Influenza Vaccine and the Risk of Relapse of Guillain-Barre Syndrome
Neurol 55:452-453, Wijdicks,E.F.M. et al, 2000
Significance of Hyperintense Vessels on FLAIR MRI in Acute Stroke
Neurol 55:265-269, Kamran,S. et al, 2000
Diffusion- and Perfusion-Weighted MRI Patterns in Borderzone Infarcts
Stroke 31:1090-1096, Chaves,C.J.,et al, 2000
How Well Does the Oxfordshire Community Stroke Project Classification Predict the Site and Size of the Infarct on Brain Imaging
JNNP 68:558-562,547, Mead,G.E.,et al, 2000
Clinical Characteristics of Pathologically Proved Cholesterol Emboli to the Brain
Neurol 54:1681-1683, Ezzeddine,M.A.,et al, 2000
Motor Strokes Sparing the Leg
Arch Neurol 57:513-518, de Freitas,G.R.,et al, 2000
Progressive Dementia and Gait Disorder in a 78 Year Old Woman
JNNP 68:526-531, Tagliati,M.,et al, 2000
Posterior Reversible Encephalopathy Syndrome: Utility of Fluid-attenuated Inversion Recovery MR Imaging in the Detection of Cortical and Subcortical Lesions
AJNR 21:1199-1206, Casey,S.O. et al, 2000
Effect of Hypervolemic Therapy on Cerebral Blood Flow After Subarachnoid Hemorrhage, A Randomized Controlled Trial
Stroke 31:383-391, Lennihan,L.,et al, 2000
Progressive Forms of MS:Classification Streamlined or Consensus Overturned?
Lancet 355:162-163, Weinshenker,B.G., 2000
A Six-Year-Old Girl with Tick paralysis
NEJM 342:90-94, Felz,M.W.,et al, 2000
Striatal Dopamine Trnasporter Binding Assessed by [I-123]IPT and Single Photon Emission Computed tomography in Patients with Early Parkinson's Disease, Implications for a Preclinical Diagnosis
Arch Neurol 57:205-208, Schwarz,J.,et al, 2000
Glatiramer Acetate (Copaxone) Treatment in Relapsing-Remitting MS
Neurol 54:813-817, Ge,Y.,et al, 2000
Nitrous Oxide Anesthesia-Associated Myelopathy
ArchNeurol 57:380-382, Marie,R.,et al, 2000
Diagnostic Criteria for Primary Progressive Multiple Sclerosis: A Position Paper
Ann Neurol 47:831-835, Thompson,A.J.,et al, 2000
Pseudoulnar Palsy From a Small Infarct of the Precentral Knob
Neurol 54:2185, Phan,T.G.,et al, 2000
Cardiac Dysfunction in Neuromuscular Diseases
The Neurologist 6:67-82, Pourmand,R., 2000
Long-Term outcome in Patients With Guillain-Barre Syndrome Requiring Mechanical Ventilation
Neurol 54:2311-2315, Fletcher,D.D.,et al, 2000
Is Fluid-attenuated Inversion Recovery MRI More Sensitive Than Conventional MRI for Hypoglycemic Brain Injury
Neurol 55:1064-1065, Bakshi,R.,et al, 2000
Venous Infarcts
Neurol Neurochir Pol 34:937-946, Mendel,T., 2000
Distribution of Cranial MRI Abnormalities in Patients with Symptomatic and Subclinical CADASIL
BJR 73:256-265, Coulthard, A.,et al, 2000
Diffusion-Weighted Magnetic Resonance Imaging in a Case of Methanol Intoxication
Neurotoxicology 21:405-408, Oppenheim, D.S.,et al, 2000
Guillain-Barre Syndrome in a Patient with Non-Hodgkins Lymphoma
Ann Oncol 11:217-220, Schwenk,D.Re.,et al, 2000
MRI of Arachnoid Granulations Within the Dural Sinuses Using a FLAIR Pulse Sequence
British Jour Radiol 72:1046-1051, Ikushima,I.,et al, 1999
Hypoxic/Ischaemic Brain Damages, Especially Pallidal Lesions, in Heroin Addicts
Forensic Sci Int 102:51-59, Andersen,S.N. &Skullerud,K., 1999
Mechanisms and Clinical Features of Posterior Border-Zone Infarcts
Neurol 53:1312-1318, Belden,J.R.,et al, 1999
Atherothrombotic Cerebellar Infarction, Vascular Lesion-MRI Correlation of 31 Cases
Stroke 30:2376-2381, Min,W.K.,et al, 1999
Posterior Cerebral Artery Territory Infarcts in the New England Medical Center Posterior Circulation Registry
Arch Neurol 56:824-832, Yamamoto,Y.,et al, 1999
Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics
Arch Neurol 56:1079-1084, Rudick,R.A., 1999
SIADH as the First Symptom of Guillain-Barre Syndrome
Neurol 53:1365, Hofmann,O.,et al, 1999
Diffusion-Weighted MR Imaging of Encephalitis
AJR 173:1097-1099, Tsuchiya,K.,et al, 1999
Normal Myelination of the Pediatric Brain Imaged with Fluid-Attenuated Inversion-Recovery (FLAIR) MR Imaging
AJNR 20:1406-1411, Murakami,J.W.,et al, 1999
A Comparison of Fast Spin-Echo, Fluid-Attenuated Inversion-Recovery, and Diffusion-Weighted MR Imaging in the First 10 Days after Cerebral Infarction
AJNR 20:1535-1542, Ricci,P.E.,et al, 1999
Nuclear Medicine in Neurology and Psychiatry
Lancet 354:1107-1111, Costa,D.C.,et al, 1999
Stroke Location is Not Associated with Return to Work After First Ischemic Stroke
Stroke 30:2568-2573, Wozniak,M.A.,et al, 1999
Population Based Cost Utility Study of Interferon Beta-1b in Secondary Progressive Multiple Sclerosis
BMJ 319:1529-1533, Forbes,R.B.,et al, 1999
Intravenous Immunoglobulin in the Treatment of Autoimmune Neuromuscular Diseases:Present Status and Practical Therapeutic Guidelines
Muscle & Nerve 22:1479-1497, Dalakas,M.C., 1999
TI-201 SPECT in Pseudotumoral Multiple Sclerosis
Clin Nucl Med 24:186-188, Obach,V.,et al, 1999
Interferon-alpha 2a Reduces MRI Disease Activity in Relapsing-Remitting Multiple Sclerosis
Neurol 52:1049-1056, Myhr,K.M.,et al, 1999
Primary and Transitional Progressive MS,A Clinical and MRI Cross-Sectional Study
Neurol 52:839-845, Stevenson,V.L.,et al, 1999
Outcome in Severe Pediatric Guillain-Barre Syndrome after Immunotherapy or Supportive Care
Neurol 52:1494-1497, Graf,W.D.,et al, 1999
Relevance of Hypointense Lesions on Fast Fluid-Attenuated Inversion Recovery MR Images as a Marker of Disease Severity in Cases of Multiple Sclerosis
AJNR 20:813-820, Rovaris,M.,et al, 1999
Clinicopath Conf:Lymphoplasmocytic Lymphoma with Motor Neuronopathy,Waldenstrom's Macroglobulinemia
NEJM 340:1661-1669, , 1999
Sensory Symptoms Restricted to Proximal Body Parts in Small Cortical Infarction
Neurol 53:889-890, Kim,J.S., 1999
Evidence of Interferon B-1a Dose Response In Relapsing-Remitting MS, The OWIMS Study
Neurol 53:679-686, The Once Weekly Interferon for MS Study Group (OWI, 1999